2026 Update: What Has Changed
Since this article was first published in 2019, the evidence for topical finasteride has evolved significantly. Here are the key developments.
Largest Real-World Study: 638,629 Patients
Yu et al. (2026) analysed 638,629 men prescribed compounded topical finasteride via a US telehealth platform — the largest study of its kind. Among 151,352 patients who completed follow-up: 80.4% reported satisfaction with treatment, and only 2.7% reported side effects. The most commonly prescribed formulation was 0.3% topical finasteride combined with 6% minoxidil. [PubMed]
Topical vs. Oral: The Safety Comparison
A 2025 pharmacovigilance study by Gupta et al. analysed the FDA Adverse Event Reporting System and found fewer signals for Post-Finasteride Syndrome-like adverse events with topical versus oral finasteride. The key reason: topical finasteride reduces scalp DHT by ~70% (equivalent to oral) but serum DHT by only 30–35% (versus 60–70% for oral). Less systemic exposure means fewer systemic side effects — approximately 2.8% sexual side effects with topical versus 4.8% with oral. [PMC]
Microneedling + Topical Finasteride: 10x Better Absorption
One of the most important findings: standard topical application reaches only 1–3% of the hair follicles. Microneedling changes this by creating thousands of microchannels, increasing absorption to 20–30% — a 10-fold improvement.
Clinical data supports this approach. A study of 45 patients found that 80% receiving microneedling + topical finasteride/minoxidil scored ≥3 on improvement scales, outperforming either treatment alone. A meta-analysis confirmed 5 times better odds of improvement with microneedling combination therapy (OR = 5.01). Even patients who failed 2–5 years of oral finasteride showed significant improvement when microneedling was added. [Expert Consensus 2025] [Meta-Analysis]
Combination Therapy Is Now Standard
A randomised study of 60 patients (Bharadwaj et al., 2023) found that topical finasteride (0.25%) combined with minoxidil (5%) was superior to either treatment alone at 24 weeks, with no significant side effects. This combination approach — attacking hair loss via both DHT blockade and blood flow stimulation — is now the most commonly prescribed formulation. [PMC]
FDA Warning (2024)
In 2024, the FDA issued a safety alert: between 2019 and 2024, 32 adverse events were reported with compounded topical finasteride, including erectile dysfunction, depression, and suicidal ideation. Importantly: no FDA-approved topical finasteride exists. Topical application does not eliminate systemic absorption. Use only under medical supervision. [FDA.gov]
HLC’s Position
HLC does not prescribe finasteride — medication management belongs to your dermatologist. We do recommend that our hair transplant patients discuss finasteride as a complementary treatment to protect their investment. We offer PRP with microneedling as an evidence-based, non-pharmaceutical option — using the same microneedling delivery principle described above.
If you’re experiencing hair loss and want an honest assessment of your options: Contact HLC Hairline Clinic. No pressure, no upselling.
Frequently Asked Questions
Is topical finasteride as effective as oral finasteride?
Yes. Clinical studies show topical finasteride reduces scalp DHT by approximately 70%, equivalent to oral. The Phase III trial (Piraccini et al., 2021, 458 patients) found comparable hair count improvements. The difference is systemic: topical reduces serum DHT by only 30–35% versus 60–70% for oral, resulting in fewer side effects.
What are the side effects of topical finasteride?
In the largest study (638,629 patients, 2026), only 2.7% reported side effects — roughly half the rate of oral finasteride. The FDA warns that systemic absorption occurs through the skin, and side effects including sexual dysfunction have been reported. Safer than oral, but not risk-free.
Is topical finasteride FDA approved?
No. As of 2026, no topical finasteride has FDA approval. It is available through compounding pharmacies in the US and approved in select EU countries (Italy, Germany, Portugal) under the brand name Finjuve.
Does microneedling improve topical finasteride results?
Dramatically. Without microneedling, scalp absorption is only 1–3%. Microneedling increases it to 20–30%. Meta-analyses show 5 times better odds of improvement with microneedling combination therapy versus topical application alone.
Can I use topical finasteride after a hair transplant?
Yes — many surgeons recommend it. Finasteride protects existing native hair from further loss, preserving your transplant result long-term. Discuss timing with your dermatologist.
Should I use topical finasteride or minoxidil?
They work differently and are best used together. Finasteride blocks DHT; minoxidil stimulates blood flow. The most common modern formulation combines both (0.3% finasteride + 6% minoxidil). Studies show this combination is superior to either treatment alone.
This article was updated in April 2026 based on peer-reviewed clinical evidence. At HLC, we continuously review the latest research to ensure our guidance reflects current best practices.
Background: Understanding Finasteride
The following sections provide detailed background on how finasteride works, its history, side effects, and alternatives.
Despite its effectiveness for male pattern baldness, it has been associated with various side effects including erectile dysfunction, decreased libido, abnormal ejaculation, insomnia, and depression.1 A topical version of the drug is currently being studied, as scientists hope to lower the incidence of side effects through a new delivery method.
Topical finasteride is not yet available commercially, but you may get it from compounding pharmacies. However, you should know that only topical minoxidil and oral finasteride were approved by the Food and Drug Administration (FDA) and European Medicines Agency (EMA) for the treatment of male pattern baldness.2 The efficacy and safety of finasteride in other forms are yet to be established.
While some of you eagerly await the approval and availability of topical finasteride, let’s discuss what androgenetic alopecia is, how finasteride works, and what are the side effects reported by people who actually used it.
What is Androgenetic Alopecia?
There are different types of hair loss that occur in both sexes. Androgenetic alopecia, also known as male pattern baldness or female pattern baldness, is the most common type of alopecia in men and women. It affects at least 30% of men by the age of 30 years and about 50% by the age of 50. While its prevalence is lower in women than in men, it still occurs to a great extent.
In men, hair-thinning starts at the temples and head’s crown, forming an M-shaped pattern. Women, on the other hand, experience hair loss, which starts in the central and frontal scalp with retention of the frontal hairline. As time passes, hair thinning may lead to complete baldness.
It is understandable how this condition affects an individual’s self-esteem. Healthy hair signifies youth and vitality, and people suffering from visible hair loss are often seen as old looking and less physically attractive. The prevalence of androgenetic alopecia and its impact on the patient’s social and psychological well-being is the reason why there’s a huge market for hair loss treatments.
The downside is that current pharmacological treatments are not entirely safe and the benefits are not maintained upon ceasing therapy. Studies have confirmed that finasteride can cause sexual and psychological side effects. There are also some evidence suggesting that such adverse effects can continue for a long time even if you stop taking the medication.
Finasteride: hair loss treatment for men
Finasteride was approved by the FDA in 1997 for male pattern baldness or hereditary hair loss.3 It is currently being sold under the brand names Propecia, Proscar, and Aindeem to name a few. Initially, the drug was only marketed to treat benign prostatic hyperplasia (BPH) or enlarged prostate in men aged 60 and above. By some sort of luck, researchers found that treated patients did not present with receding hairlines, which prompted large-scale clinical trials to test the effectiveness of finasteride for AGA. Right now, it is also being used off-label (unapproved indication) to treat hirsutism or excessive hair growth in women, as well as a hormone replacement therapy for transgender women.
However, this medication is only approved for MEN with AGA. It is not recommended to treat female pattern hair loss, especially in women of childbearing potential, as it can cause abnormalities to the external genitalia of the male fetus. In fact, the drug label for oral finasteride (Propecia®) states, “women who are pregnant or may become pregnant should not handle crushed or broken PROPECIA tablets.”4 Additionally, studies have found it ineffective in treating AGA in women.5
With that being said, it’s not illegal to prescribe finasteride to women with hair loss. As I’ve mentioned above, certain medications may be prescribed to treat conditions that has not been included in its indications; it’s called off-label usage, and it depends on the discretion of the prescribing physician.
How does Finasteride work?
It has been found that AGA does not occur in individuals with a genetic deficiency of the type 2 5-alpha-reductase, an enzyme essential in converting the male sex hormone testosterone to the more potent dihydrotestosterone (DHT). Increased levels of DHT are said to be responsible in causing hair loss, but it’s not the presence of DHT alone that should be addressed. Men who are predisposed to AGA have an increased sensitivity to DHT. The genetically predisposed hair follicles in these men are prone to hair miniaturization, which leads to progressive decline in scalp hair density.
HAIR FOLLICLE MINIATURIZATION
Normal terminal hairs that are large, thick, and pigmented are converted into thin, barely visible, depigmented hairs called vellus hairs.
Finasteride is a synthetic compound that blocks the activity of 5-alpha-reductase enzyme, causing reduction of scalp DHT by 64% and serum DHT by 68%.6 This makes the drug effective in reducing the size of an enlarged prostate. DHT may be the culprit in male pattern hair loss; however, it is also an important hormone for the formation of sexual characteristics during puberty. This means finasteride should not be used by men below the age of 18.
Safety and Efficacy of Finasteride according to Studies
Is finasteride effective in treating hair loss? The mere fact that finasteride was granted an FDA and EMA approval means experts have found the drug effective for male pattern baldness. The therapeutic dose for treating AGA is 1 mg tablet to be taken by mouth once daily and 5 mg for enlarged prostate. When Merck launched Propecia for male pattern baldness in the late 90s, it was a blockbuster drug. Back then, the label only warned that about 1% of men might experience erectile dysfunction and low libido.
It did not warn about other possible forbidding symptoms such as insomnia, depression, or suicidal ideation. What’s even worse was their claim that– “these (sexual) side effects went away in men who stopped taking Propecia.” It turns out that the bad effects of the drug stay longer in some individuals.
A 2015 review, published in JAMA Dermatology, found that out of 34 clinical trial reports for finasteride, none had adequately assessed the safety of the drug.7 It is troubling to know that millions of patients had been using finasteride for years before the company decided to update the drug’s label in 2012. It has since added depression to the label and acknowledge patients’ reports that the drug’s sexual side effects may continue even after discontinuation of treatment.
So once you decide to stop taking the drug, hair loss comes back and side effects may also remain. No matter how many times you toss the coin, it looks like you are fighting a losing battle.
This data raises the question of why would anyone choose to take a medication that can possibly
Here’s another thing to consider:
Normal terminal hairs that are large, thick, and pigmented are converted into thin, barely visible, depigmented hairs called vellus hairs.8
The Post-Finasteride Syndrome
More than 1,300 lawsuits were filed against Merck, as patients claimed that the symptoms of erectile dysfunction, loss of libido, reduction in penis size, cognitive impairment, and depression severely affected their families, relationships, and careers—even drove some people to take their own lives. Cases of sexual side effects, depression, and suicide had been alarming that patients coined the term post-finasteride syndrome, referring to the group of symptoms that patients experience even after stopping treatment.9
The non-profit organization, the Post-Finasteride Syndrome Foundation (www.pfsfoundation.org), is dedicated in supporting finasteride patients and improving public awareness of the condition. Physicians are now advised to refrain from prescribing oral finasteride to patients with a history of sexual dysfunction, fertility problems, and depression.9
Common and Uncommon Side Effects
Now let’s take a look at side effects and risks associated with finasteride use. The adverse effects from the two studies are presented in order of decreasing incidence.
As with all medications, side effects differ from person to person. Some patients may experience mild and self-limiting symptoms. Other may experience severe symptoms that persist even after treatment discontinuation.
A group of researchers also found some uncommon side effects associated with finasteride use. The subjects were treated with 1 mg finasteride for at least four months. A few patients experienced the following side effects:10
- Melasma (1 patients)
- Dry/thinning of skin (4 patients)
- Tinnitus (3 patients)
- Postural hypotension (2 patients)
- Oral lesions (9 patients)
Finasteride alternative
The worrisome side effects associated with finasteride is enough for anyone to reconsider taking the drug. Does the benefits outweigh the risks? There are other approved drug therapies for AGA. However, even though most of them can stop the progression of hair loss, none can promise a permanent cure.
Other Drug Therapies for Androgenetic Alopecia13
| Drug Name | Approval | Approval | Route |
| Minoxidil (Rogaine) | Approved (male and female) | Vasodilator | Topical |
| Pinacidil (Pindac) | Clinical Trial | Vasodilator | Topical |
| Tretinoin (Retin-A) | Clinical Trial | Retinoid | Topical |
| Dutasteride (Avodart) | Approved (male) | 5-α-R inhibitor | Oral |
| Bicalutamide (Casodex) | Clinical Trial | Nonsteroidal anti-androgen | Oral |
| Fluridil (Eucapil) | Clinical Trial | Nonsteroidal anti-androgen | Topical |
| Eclipta alba extract | Animal Trial (mice) | Botanical extract | Topical |
| Antisense oligonucleotides | Investigational | – |
Natural supplements, diet modifications, and combination therapies are also worth considering if you want to avoid the ugly side effects of finasteride. In some cases, male pattern baldness may also be due to an underlying medical condition. In one study, AGA have been linked to obesity or being overweight.
Inadequate food intake and personal food choices may lead to dietary deficiencies. Some micronutrients that are relevant to hair growth include:
- B vitamins (biotin, niacin, folic acid, riboflavin, pantothenic acid, pyridoxine, and cyanocobalamin)
- Antioxidants (vitamin A and E)
- Trace metals (iron, zinc, and selenium)
Hair loss does not often result from a single cause, but from a combination of several factors that must be addressed altogether for treatment success. To manage male pattern baldness, it is important for patients and clinicians to be aware of the variety of current therapeutic options available for them.
Related reading: Exosome Hair Treatment: What Actually Works — And What’s Just Marketing →
